Mastrapasqua Asset Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $2.48M | Sell |
|
|||||
|
2023
Q2 | $2.67M | Sell |
|
|||||
|
2023
Q1 | $2.57M | Sell |
|
|||||
|
2022
Q4 | $2.97M | Sell |
|
|||||
|
2022
Q3 | $2.72M | Buy |
|
|||||
|
2022
Q2 | $2.92M | Sell |
|
|||||
|
2022
Q1 | $4.07M | Sell |
|
|||||
|
2021
Q4 | $5.68M | Sell |
|
|||||
|
2021
Q3 | $6.43M | Sell |
|
|||||
|
2021
Q2 | $5.84M | Buy |
|
|||||
|
2021
Q1 | $4.46M | Buy |
|
|||||
|
2020
Q4 | $3.18M | Sell |
|
|||||
|
2020
Q3 | $3.04M | Sell |
|
|||||
|
2020
Q2 | $2.37M | Buy |
|
|||||
|
2020
Q1 | $1.71M | Sell |
|
|||||
|
2019
Q4 | $2.09M | Buy |
|
|||||
|
2019
Q3 | $1.79M | Buy |
|
|||||
|
2019
Q2 | $1.91M | Buy |
|
|||||
|
2019
Q1 | $1.95M | Sell |
|
|||||
|
2018
Q4 | $1.52M | Buy |
|
|||||
|
2018
Q3 | $1.77M | Sell |
|
|||||
|
2018
Q2 | $1.5M | Buy |
|
|||||
|
2018
Q1 | $950K | Buy |
|
|||||
|
2017
Q4 | $883K | Sell |
|
|||||
|
2017
Q3 | $931K | Buy |
|